Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

RedHill Biopharma (RDHL) Interest Expenses: 2009-2024

Historic Interest Expenses for RedHill Biopharma (RDHL) over the last 16 years, with Dec 2024 value amounting to $2.1 million.

  • RedHill Biopharma's Interest Expenses fell 54.30% to $1.9 million in Q2 2023 from the same period last year, while for Jun 2023 it was $36.6 million, marking a year-over-year increase of 131.50%. This contributed to the annual value of $2.1 million for FY2024, which is 78.59% down from last year.
  • According to the latest figures from FY2024, RedHill Biopharma's Interest Expenses is $2.1 million, which was down 78.59% from $9.6 million recorded in FY2023.
  • In the past 5 years, RedHill Biopharma's Interest Expenses registered a high of $42.4 million during FY2022, and its lowest value of $2.1 million during FY2024.
  • In the last 3 years, RedHill Biopharma's Interest Expenses had a median value of $9.6 million in 2023 and averaged $18.0 million.
  • Per our database at Business Quant, RedHill Biopharma's Interest Expenses soared by 2,813.01% in 2020 and then tumbled by 78.59% in 2024.
  • Yearly analysis of 5 years shows RedHill Biopharma's Interest Expenses stood at $12.8 million in 2020, then soared by 30.57% to $16.7 million in 2021, then spiked by 154.42% to $42.4 million in 2022, then crashed by 77.34% to $9.6 million in 2023, then tumbled by 78.59% to $2.1 million in 2024.